S357-0068 Screening compound: 1-[(6-PHENYL-5,6-DIHYDRO-8H-IMIDAZO[5,1-C][1,4]OXAZIN-1-YL)CARBONYL]-N-(4-PYRIDYLMETHYL)-4-PIPERIDINECARBOXAMIDE

S357-0068 Screening compound: 1-[(6-PHENYL-5,6-DIHYDRO-8H-IMIDAZO[5,1-C][1,4]OXAZIN-1-YL)CARBONYL]-N-(4-PYRIDYLMETHYL)-4-PIPERIDINECARBOXAMIDE
S357-0068 Screening compound: 1-[(6-PHENYL-5,6-DIHYDRO-8H-IMIDAZO[5,1-C][1,4]OXAZIN-1-YL)CARBONYL]-N-(4-PYRIDYLMETHYL)-4-PIPERIDINECARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound S357-0068
1-[(6-PHENYL-5,6-DIHYDRO-8H-IMIDAZO[5,1-C][1,4]OXAZIN-1-YL)CARBONYL]-N-(4-PYRIDYLMETHYL)-4-PIPERIDINECARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S357-0068

Molecular Formula

C25H27N5O3 (C25 H27 N5 O3)

Compound Name

1-[(6-PHENYL-5,6-DIHYDRO-8H-IMIDAZO[5,1-C][1,4]OXAZIN-1-YL)CARBONYL]-N-(4-PYRIDYLMETHYL)-4-PIPERIDINECARBOXAMIDE

IUPAC name

n/a

SMILES

O=C(C(CC1)CCN1C(c1c(COC(C2)c3ccccc3)n2cn1)=O)NCc1ccncc1

InChI

InChI=1S/C25H27N5O3/c31-24(27-14-18-6-10-26-11-7-18)20-8-12-29(13-9-20)25(32)23-21-16-33-22(15-30(21)17-28-23)19-4-2-1-3-5-19/h1-7,10-11,17,20,22H,8-9,12-16H2,(H,27,31)/t22-/m1/s1

InChI Key

GSYRBEHKTCFQDT-JOCHJYFZSA-N

MDL Number (MFCD)

MFCD29000686

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

445.52

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

0.394

Distribution Coefficient, logD

0.391

Water Solubility, LogSw

-1.05

Polar Surface Area

70.412

Acid Dissociation Constant (pKa)

13.00

Base Dissociation Constant (pKb)

5.29

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.00

S357-0068 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bromodomain Modulators Library (5801 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S357-0068 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S357-0068?
Check Price and Availability of S357-0068, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S357-0068 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S357-0068
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S357-0068
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S357-0068 available by request